Replies to post #123875 on Biotech Values

[projectchris]

The NEO3-06 trial comparing lymphoseek to radical ALND in Head & Neck cancers will be a very interesting study imho. I think enrollment for Head & Neck is currently at 190 patients, so I suspect the interim analysis is near.

correction radical neck dissection.